Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway

M-A Gallego; Caroline Ballot; Jérôme Kluza; N Hajji; Alain Martoriati; Laurent Castéra; Clara Santos‐Cuevas; Pierre Formstecher; Bertrand Joseph; Guido Guido Kroemer; Christian Bailly; Philippe Marchetti

doi:10.1038/sj.onc.1210833

Related publications

Article2004

Apoptosis-inducing factor determines the chemoresistance of non-small-cell lung carcinomas

Miguel-Angel Gallego, Bertrand Joseph, Therese H Hemström, Susan Tamiji, Laurent Mortier, Guido Guido Kroemer, Pierre Formstecher, Boris Zhivotovsky, Philippe Marchetti

Article2013

Prognostic value of LIPC in non-small cell lung carcinoma

Lorenzo Galluzzi, Aïcha Goubar, Ken A. Olaussen, Ilio Vitale, Laura Senovilla, Judith Michels, Angélique Robin, Nicolas Dorvault, Benjamin Besse, Pierre Validire, Pierre Fouret, Carmen Behrens, Ignacio I. Wistuba, Jean‐Charles Soria, Guido Guido Kroemer

Article2017

Gefitinib: an “orphan” drug for non-small cell lung cancer

Dimitrios C. Ziogas, Michalis Liontos, Anastasios Kyriazoglou, Georgios Tsironis, Aristotelis Bamias, Meletios A Dimopoulos

Article1990

Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.

Demetrios�� Spandidos, S Zakinthinos, Constantina Petraki, Flora Sotsiou, M Yiagnisis, Meletios A Dimopoulos, Charis Roussos, John K. Field

Article2012

Proangiogenic enzymes in non-small cell lung carcinoma — An interplay between thymidine phosphorylase and heme oxygenase-1?

Magdalena Tertil, Klaudia Skrzypek, Kazimierz Węglarczyk, Chantal Pichon, Claudine Kiéda, Halina Waś, Alicja Józkowicz, Jozef Dulak